Answers are grounded in this paper and cite their sources.
Managing exposure to cytotoxic drugs is difficult because of high toxicity and lack of health-based exposure limits. Cytotoxic drugs are often prepared and supplied to hospitals by compounding pharmacies. These pharmacies often use a combination of cytotoxic drug safety cabinets (CDSC), respiratory protective equipment (RPE), disposable coveralls, and gloves to reduce the risk of exposure. However, work practices play a crucial role in the overall effectiveness of these controls. We assessed the impact of enhanced work practices on the effectiveness of these controls. We reviewed the work practices through direct observations and took surface wipe samples for Cyclophosphamide before and after the recommended improvements to evaluate the impact. The surface wipe samples were taken from the CDSC and compounding room (red zone), the secondary change room (yellow), and the control areas (green). We compared the results with the respective adopted performance-based surface limits (PBSLs). Before improvements, the cyclophosphamide levels in each zone and on the reusable RPE exceeded the PBSLs. The cyclophosphamide levels ranged between <0.003 and 2.3 µg/100 cm2, with the highest level inside the CDSC. After improvements, the cyclophosphamide levels ranged between <0.003 and 0.3 µg/100 cm2, and there was no exceedance of PBSLs. The work practices are crucial to the effectiveness of the CDSC and personal protective equipment for handling cytotoxic drugs. Surface wipe sampling is a handy tool for evaluating work practices. In addition, we recommend monitoring cyclophosphamide levels in the urine to determine the overall effectiveness of controls.
No takes yet. Share an insight, caveat, or question.
Ritesh Patel (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: